期刊
DEVELOPMENTAL CELL
卷 56, 期 23, 页码 3250-+出版社
CELL PRESS
DOI: 10.1016/j.devcel.2021.10.006
关键词
-
资金
- National Natural Science Foundation of China [92054301, 31790403]
- Chinese Ministry of Science and Technology [2017YFA0503401]
- Key Research Program of Frontier Sciences, CAS [QYZDY-SSWSMC006]
The study reveals that SARS-CoV-2 ORF3a promotes lysosomal exocytosis, enhancing viral release, while this mechanism is absent in SARS-CoV ORF3a. Specific residues are identified as crucial for promoting lysosomal exocytosis.
Viral entry and egress are important determinants of virus infectivity and pathogenicity. beta-coronaviruses, including the COVID-19 virus SARS-CoV-2 and mouse hepatitis virus (MHV), exploit the lysosomal exocytosis pathway for egress. Here, we show that SARS-CoV-2 ORF3a, but not SARS-CoV ORF3a, promotes lysosomal exocytosis. SARS-CoV-2 ORF3a facilitates lysosomal targeting of the BORC-ARL8b complex, which mediates trafficking of lysosomes to the vicinity of the plasma membrane, and exocytosis-related SNARE proteins. The Ca2+ channel TRPML3 is required for SARS-CoV-2 ORF3a-mediated lysosomal exocytosis. Expression of SARS-CoV-2 ORF3a greatly elevates extracellular viral release in cells infected with the coronavirus MHV-A59, which itself lacks ORF3a. In SARS-CoV-2 ORF3a, Ser171 and Trp193 are critical for promoting lysosomal exocytosis and blocking autophagy. When these residues are introduced into SARSCoV ORF3a, it acquires the ability to promote lysosomal exocytosis and inhibit autophagy. Our results reveal a mechanism by which SARS-CoV-2 interacts with host factors to promote its extracellular egress.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据